SCHEMBL21596785

SCHEMBL21596785

CCOc1ccc2onc(N)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.43
TERT O14746 1/20 0.43
ABCB11 O95342 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPC1 O15118 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
TP53 P04637 2/20 0.42
CYP3A4 P08684 2/20 0.42
MAP4K4 O95819 1/20 0.42
HSD17B10 Q99714 4/20 0.41
NQO1 P15559 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29652574 1.00 KDM4E (0.47) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL21596857 0.87 HTR3A (0.47) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL19142570 0.82 KDM4E (0.51) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6955470 0.81 ALDH1A1 (0.47) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL29652612 0.81 ALDH1A1 (0.47) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL31432494 0.76 ROCK1 (0.41) MAP4K4
SCHEMBL12044601 0.75 RAB9A (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL21596922 0.74 KMT2A (0.50) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL21609212 0.74 EPHX2 (0.46) KDM4ELMNABLMNPC1TP53
SCHEMBL29652544 0.74 EPHX2 (0.46) KDM4ELMNABLMNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
WO-2025007873-A1 KAT6 INHIBITOR 上海齐鲁制药研究中心有限公司 2025-01-09 WO disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
CN-112334466-A Compound (I) CTXT私人有限公司 2021-02-05 CN disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 KDM4E 4009/4885ALDH1A1 981/4885HPGD 753/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 KDM4E 4009/4885ALDH1A1 982/4885HPGD 752/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B KDM4E 800/4885ALDH1A1 1864/4885HPGD 4289/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 KDM4E 4009/4885ALDH1A1 982/4885HPGD 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.